BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 23010234)

  • 1. Comparison of the long-term efficacy of 3- and 5-year house dust mite allergen immunotherapy.
    Stelmach I; Sobocińska A; Majak P; Smejda K; Jerzyńska J; Stelmach W
    Ann Allergy Asthma Immunol; 2012 Oct; 109(4):274-8. PubMed ID: 23010234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
    Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
    Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficacy of allergen immunotherapy: what do we expect?
    Frati F; Dell'Albani I; Incorvaia C
    Immunotherapy; 2013 Feb; 5(2):131-3. PubMed ID: 23413904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of oral steroids with and without vitamin D3 on early efficacy of immunotherapy in asthmatic children.
    Majak P; Rychlik B; Stelmach I
    Clin Exp Allergy; 2009 Dec; 39(12):1830-41. PubMed ID: 19817753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific allergen immunotherapy: effect on immunologic markers and clinical parameters in asthmatic children.
    Cevit O; Kendirli SG; Yilmaz M; Altintas DU; Karakoc GB
    J Investig Allergol Clin Immunol; 2007; 17(5):286-91. PubMed ID: 17982919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of 1-year specific immunotherapy with standardized house dust mite vaccine on mild to moderate allergic asthmatic patients].
    Wang HY; Lin XP; Hao CL; Zhang CQ; Sun BQ; Zheng JP; Chen P; Sheng JY; Wu A; Zhong NS
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Oct; 29(10):679-87. PubMed ID: 17129496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma.
    Ozdemir C; Yazi D; Gocmen I; Yesil O; Aydogan M; Semic-Jusufagic A; Bahceciler NN; Barlan IB
    Pediatr Allergy Immunol; 2007 Sep; 18(6):508-15. PubMed ID: 17680909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dermatophagoides pteronyssinus allergen-specific immunotherapy on the serum interleukin-13 and pulmonary functions in asthmatic children.
    Chen ZG; Li M; Chen YF; Ji JZ; Li YT; Chen W; Chen FH; Chen H
    Chin Med J (Engl); 2009 May; 122(10):1157-61. PubMed ID: 19493463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan.
    Niu CK; Chen WY; Huang JL; Lue KH; Wang JY
    Respir Med; 2006 Aug; 100(8):1374-83. PubMed ID: 16403616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: a randomized, double-blind, placebo-controlled trial.
    Mosbech H; Deckelmann R; de Blay F; Pastorello EA; Trebas-Pietras E; Andres LP; Malcus I; Ljørring C; Canonica GW
    J Allergy Clin Immunol; 2014 Sep; 134(3):568-575.e7. PubMed ID: 24797423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The impact of subcutaneous immunotherapy with Dermatophagoides farinae and Dermatophagoides pteronyssinus on the quality of life of patients with allergic rhinitis and asthma].
    Yepes-Núñez JJ; Gómez C; Espinoza Y; Cardona R
    Biomedica; 2014; 34(2):282-90. PubMed ID: 24967933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.
    Halken S
    Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bronchial allergen provocation: a useful method to assess the efficacy of specific immunotherapy in children.
    Rosewich M; Arendt S; El Moussaoui S; Schulze J; Schubert R; Zielen S
    Pediatr Allergy Immunol; 2013 Aug; 24(5):434-40. PubMed ID: 23578317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of allergen-specific immunotherapy on plasma level of platelet factor 4 (PF-4) and beta-thromboglobulin (beta-TG), platelet activation markers in patients with house dust mite allergy.
    Kasperska-Zajac A; Brzoza Z; Rogala B
    Vaccine; 2007 May; 25(18):3595-8. PubMed ID: 17291641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validated safety predictions of airway responses to house dust mite in asthma.
    Ravensberg AJ; van Rensen EL; Grootendorst DC; de Kluijver J; Diamant Z; Ricciardolo FL; Sterk PJ
    Clin Exp Allergy; 2007 Jan; 37(1):100-7. PubMed ID: 17210047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial.
    Eifan AO; Akkoc T; Yildiz A; Keles S; Ozdemir C; Bahceciler NN; Barlan IB
    Clin Exp Allergy; 2010 Jun; 40(6):922-32. PubMed ID: 20100188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical efficacy of a standardized specific immunotherapy against house dust mite in 85 asthmatic children].
    Zhang X; Li MR; Wang C; Wang XN; Zhang HL; Lin J; Jin K; Li YC
    Zhonghua Er Ke Za Zhi; 2010 Jul; 48(7):526-30. PubMed ID: 21055090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study.
    Lue KH; Lin YH; Sun HL; Lu KH; Hsieh JC; Chou MC
    Pediatr Allergy Immunol; 2006 Sep; 17(6):408-15. PubMed ID: 16925685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of a cluster specific immunotherapy in children with bronchial asthma and mite allergy.
    Schubert R; Eickmeier O; Garn H; Baer PC; Mueller T; Schulze J; Rose MA; Rosewich M; Renz H; Zielen S
    Int Arch Allergy Immunol; 2009; 148(3):251-60. PubMed ID: 18849616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful management of mite-allergic asthma with modified extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae in a double-blind, placebo-controlled study.
    García-Robaina JC; Sánchez I; de la Torre F; Fernández-Caldas E; Casanovas M
    J Allergy Clin Immunol; 2006 Nov; 118(5):1026-32. PubMed ID: 17088125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.